Zewei Zhang, Yien Xu, Jixiang Hou, Zhaohui Liang, Yingxue Wang, Gaowa Jin et al. E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma. // npj Precision Oncology. – 2026. – DOI: 10.1038/s41698-026-01773-8. – URL: https://www.nature.com/articles/s41698-026-01773-8
Zewei Zhang, Yien Xu, Jixiang Hou, Zhaohui Liang, Yingxue Wang, Gaowa Jin, Wenjuan Wang, Shuqin Deng, Ying Jiang, Dan Tian, Jiali Gao, Juan Zhao, Yalong Han, Lei Zhao, Guokai Feng, Jianjun Li, & Quanfu Li (2026). E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma. npj Precision Oncology. https://doi.org/10.1038/s41698-026-01773-8
Zewei Zhang, et al. “E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma.” npj Precision Oncology, 2026. doi:10.1038/s41698-026-01773-8.
@article{Zhang2026,
title = {E2F1 signatures stratify immunotherapy response and reveal YWHAQ vulnerability in esophageal squamous cell carcinoma},
author = {Zhang, Zewei and Xu, Yien and Hou, Jixiang and Liang, Zhaohui and Wang, Yingxue and Jin, Gaowa and Wang, Wenjuan and Deng, Shuqin and Jiang, Ying and Tian, Dan and Gao, Jiali and Zhao, Juan and Han, Yalong and Zhao, Lei and Feng, Guokai and Li, Jianjun and Li, Quanfu},
journal = {npj Precision Oncology},
year = {2026},
doi = {10.1038/s41698-026-01773-8},
url = {https://www.nature.com/articles/s41698-026-01773-8}
}